PROSTALUND CORETHERM SYSTEM AND PROSTALAND CORETHERM ACCESSORIES

System, Hyperthermia, Rf/microwave (benign Prostatic Hyperplasia),thermotherapy

FDA Premarket Approval P010055 S009

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for a manufacturing site located at orifice medical ab in ystad, sweden.

DevicePROSTALUND CORETHERM SYSTEM AND PROSTALAND CORETHERM ACCESSORIES
Classification NameSystem, Hyperthermia, Rf/microwave (benign Prostatic Hyperplasia),thermotherapy
Generic NameSystem, Hyperthermia, Rf/microwave (benign Prostatic Hyperplasia),thermotherapy
ApplicantPROSTALUND AB
Date Received2014-02-21
Decision Date2014-07-30
PMAP010055
SupplementS009
Product CodeMEQ
Advisory CommitteeGastroenterology/Urology
Supplement TypeNormal 180 Day Track No User Fee
Supplement ReasonLocation Change - Manufacturer/sterilizer/packager/supplier
Expedited ReviewNo
Combination Product No
Applicant Address PROSTALUND AB scheelevagen 17 se-223 63 Lund SE-22-223

Supplemental Filings

Supplement NumberDateSupplement Type
P010055Original Filing
S011 2021-06-03 30-day Notice
S010
S009 2014-02-21 Normal 180 Day Track No User Fee
S008
S007 2009-09-09 Normal 180 Day Track
S006 2009-04-02 Normal 180 Day Track No User Fee
S005 2009-04-02 Normal 180 Day Track No User Fee
S004 2007-05-25 30-day Notice
S003 2006-11-22 30-day Notice
S002 2004-09-30 Normal 180 Day Track No User Fee
S001 2004-07-30 Normal 180 Day Track

NIH GUDID Devices

Device IDPMASupp
07350081910082 P010055 009
07350081910075 P010055 009
07350081910068 P010055 009
07350081910051 P010055 009
07350081910044 P010055 009
07350081910037 P010055 009
07350081910020 P010055 009
07350081910013 P010055 009

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.